Telerehabilitation platform for heart disease recovery
CardioSafe Plus: A Platform for Telerehabilitation and Monitoring of Patients With Heart Problems.
NA · University of Salamanca · NCT05865158
This study tests if a new online exercise program can help people with heart disease recover better at home.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 60 Years and up |
| Sex | All |
| Sponsor | University of Salamanca (other) |
| Locations | 1 site (Salamanca) |
| Trial ID | NCT05865158 on ClinicalTrials.gov |
What this trial studies
This intervention evaluates the effectiveness of the CardioSafe+ digital platform in aiding recovery for individuals with cardiovascular diseases. A total of 60 participants will engage in a structured six-week home-exercise program using this platform. Key assessments will include maximal respiratory pressures, exertion capacity, and subjective sensation of exertion to gauge improvements in physical well-being. The goal is to collect data before and after the intervention to determine the platform's effectiveness in managing cardiovascular complications.
Who should consider this trial
Good fit: Ideal candidates are individuals with stable cardiovascular conditions that have persisted for over a year and who have access to the necessary technology.
Not a fit: Patients with contraindications for physical activity or those experiencing acute episodes of cardiovascular disease may not benefit from this intervention.
Why it matters
Potential benefit: If successful, this platform could enhance recovery and rehabilitation for patients with heart problems, leading to improved health outcomes.
How similar studies have performed: Other studies have shown promise in using telerehabilitation for cardiovascular recovery, suggesting that this approach could be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * People who present a cardiovascular pathology with more than one year of evolution. * To be in a stable medical situation. * To have access to technological resources and knowledge for their use. Exclusion Criteria: * People who present any contraindication established for carrying out physical activity. * People who present insufficient capacity to understand and obey the instructions offered by the researchers, both in the evaluation and in the intervention. * People who have a cardiac pathology with obvious fluctuations in the course of the disease. * The presence of an acute episode of the disease during the intervention period.
Where this trial is running
Salamanca
- Beatriz María Bermejo Gil — Salamanca, Spain (RECRUITING)
Study contacts
- Principal investigator: Beatriz María Bermejo Gil — University of Salamanca
- Study coordinator: Beatriz María Bermejo Gil, Dr
- Email: beatriz.bermejo@usal.es
- Phone: 622289468
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cardiovascular Diseases